Jnj Q3 Earnings 2024. October 17, 2023 · 3 min read. Pfizer last posted its quarterly earnings data on january 30th, 2024.
Pfizer last posted its quarterly earnings data on january 30th, 2024. For fiscal 2024, analysts anticipate eps will come in at $8.31 on revenue of $162.62 billion.
The Operational Sales Growth, A Metric Excluding Currency.
Johnson & johnson's free cash flow for this purpose was approximately $920 million in the third quarter of 2023, an increase of $550 million from the prior quarter.
Johnson &Amp; Johnson Reiterated That 2024 Earnings Should Come In Around $10.55 To $10.75 A Share.
Operational sales are expected to rise 5% to 6%, suggesting a.
October 17, 2023 · 3 Min Read.
Images References :
Reported Sales Growth Of 1.9% To $23.8 Billion With Operational.
Read the earnings press release, which includes full financial data for the third quarter of 2023.
Price As Of March 22, 2024, 4:00 P.m.
(nyse:nke) today reported fiscal 2024 financial results for its third quarter ended february 29, 2024.